highperformr logo

DBV Technologies's Overview

Total employees193
HeadquartersMontrouge
Founded

DBV Technologies is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel treatments for patients with food allergies and other immunological diseases. Their proprietary Viaskin™ platform is an investigational epicutaneous immunotherapy (EPIT™) method designed to deliver biologically active compounds to the immune system through intact skin. DBV's primary focus is on food allergies, with its lead product candidate, Viaskin™ Peanut, being developed for the treatment of peanut allergy in children aged 1 to 3 years. The company aims to provide safe, effective, and patient-friendly solutions to address significant unmet medical needs in allergy care.

Where is DBV Technologies's Headquarters?

HQ Function

Serves as the central hub for research and development, corporate strategy, administrative functions, and European operations.

Notable Features:

Modern office and laboratory facilities designed to support biopharmaceutical research and development activities.

Work Culture:

A science-driven, innovative, and collaborative environment focused on advancing allergy treatments. Emphasis on patient impact and scientific rigor.

HQ Significance:

The Montrouge headquarters is critical for DBV's core R&D efforts, global operational oversight, and strategic decision-making for its Viaskin platform.

Values Reflected in HQ: The headquarters likely reflects DBV's commitment to innovation, scientific excellence, and a patient-first approach in its design and operational focus.

Location:

DBV Technologies operates with a focused global strategy, primarily centered in Europe and North America. Its headquarters in France drives global research, development, and corporate functions. The U.S. office is crucial for clinical trials, FDA interactions, and future commercialization in the significant North American market. While manufacturing partnerships may extend their reach, their direct operational presence is concentrated in these key pharmaceutical regions to advance their allergy immunotherapy pipeline worldwide.

Street Address:

177-181 avenue Pierre Brossolette

City:

Montrouge

State/Province:

Île-de-France

Country:

France

DBV Technologies's Global Presence

Basking Ridge, New Jersey, USA

Address: 150 Allen Road, Basking Ridge, NJ 07920, USA

To facilitate engagement with the U.S. Food and Drug Administration (FDA), manage clinical trial sites across North America, and build a commercial presence for future product launches in the U.S. market.

Buying Intent Signals for DBV Technologies

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of DBV Technologies

As of April 2025, DBV Technologies' leadership includes:

Daniel Tassé - Chief Executive Officer
Sébastien Robitaille - Chief Financial Officer
Dr. Pharis Mohideen - Chief Medical Officer
Timothy E. Morris - Chief Operating Officer
Caroline Dupont - Chief People Officer
Virginie Boucinha - Chief Legal Officer

Investors of DBV Technologies

DBV Technologies has been backed by several prominent investors over the years, including:

Bpifrance Participations SA
Sofinnova Partners
Baker Bros. Advisors LP
Boxer Capital, LLC
Perceptive Advisors LLC

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Over the last 12-18 months, DBV Technologies has significantly strengthened its executive team with several key appointments, indicating a period of strategic reinforcement. No major executive departures have been publicly announced in the immediate past 12 months (May 2023-May 2024), suggesting leadership stability focused on advancing clinical programs.

New Appointments:

Caroline Dupont, Caroline Dupont appointed as Chief People Officer to lead human resources and organizational development.
Virginie Boucinha, Virginie Boucinha appointed as Chief Legal Officer, overseeing legal and compliance functions.
Timothy E. Morris, Timothy E. Morris joined as Chief Operating Officer to manage company operations and strategic execution.

Technology (Tech Stack) used by DBV Technologies

Discover the tools DBV Technologies uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

DBV Technologies Email Formats and Examples

DBV Technologies commonly uses the email format combining the first initial and last name. Understanding this pattern can be helpful for professional communication.

[first_initial][last]@dbv-technologies.com

Format

jdoe@dbv-technologies.com

Example

85%

Success rate

News and media

GlobeNewswireMay 2, 2024

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

DBV Technologies announced its financial results for the first quarter of 2024, highlighting a cash position of $108.5 million. The company continues to focus on the VITESSE Phase 3 clinical trial for Viaskin Peanut in children aged 1-3 and is preparing for potential BLA submission....more

GlobeNewswireMarch 7, 2024

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

DBV Technologies provided its full-year 2023 financial results and a business update, detailing progress on its clinical programs, particularly the Viaskin Peanut EPIT development. The company reiterated its commitment to advancing treatments for food allergies....more

European Pharmaceutical ReviewFebruary 26, 2024

Viaskin Peanut shows long-term benefits for peanut allergy

A study (PEOPLE Phase III) showed long-term clinical benefits of Viaskin Peanut epicutaneous immunotherapy (EPIT) for children with peanut allergies aged four to 11 years. Findings suggest sustained desensitisation even after treatment cessation....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including DBV Technologies, are just a search away.